Agostino Antolino
Ragusa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients.
Journal: Hematology, transfusion and cell therapy
Published: November 30, 2022
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
Journal: The New England journal of medicine
Published: May 12, 2021
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts.
Journal: Frontiers in pharmacology
Published: February 18, 2021
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors.
Journal: Frontiers in oncology
Published: April 03, 2019
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Journal: International journal of molecular sciences
Published: March 23, 2019
High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 01, 2017
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.
Journal: American journal of hematology
Published: August 10, 2016
Frontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia.
Journal: Neoplasia (New York, N.Y.)
Published: May 14, 2016
The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm.
Journal: Blood transfusion = Trasfusione del sangue
Published: January 31, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026